Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05314608 · ClinicalTrials.gov registry record
Knee Related Subchondral Bone Lesions Treated With IOBP
A clinical trial of Subchondral Cyst, sponsored by Arthrex.
- Recruiting
- Registry status
- 100
- Enrollment target
- 5
- Study locations
NCT05314608: Recruiting study of Subchondral Cyst, sponsored by Arthrex.
NCT05314608 is a study of Subchondral Cyst that is actively recruiting participants, run by Arthrex. The registered enrollment target is 100 participants. The trial reports 5 study locations across 5 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05314608, a study of Subchondral Cyst, is actively recruiting participants, sponsored by Arthrex.
- RECRUITING
- Registry status
- 100 participants
- Enrollment target
- 5
- Study locations
Study Summary
The study will be a prospective, multicenter clinical study evaluating clinical and patient reported outcome measures of subjects receiving IOBP® surgical technique using Angel cPRP and BMA processing system to treat subchondral bone pathology (SBP).
Primary Outcome
To evaluate if IOBP® procedure will prevent further surgical intervention (i.e., knee replacement surgery, HTO, or calcium phosphate stabilization of SBP) when used to treat symptomatic SBP of the knee.
Conditions Studied
Interventions
- COMBINATION_PRODUCT IntraOsseous BioPlasty® (IOBP®) Surgical Technique into the knee
Study Locations (5)
Colorado
- University of Colorado Sports Medicine - Denver
Florida
- Andrews Research and Education Foundation - Gulf Breeze
Maryland
- TidalHealth Peninsula Regional, Inc. - Salisbury
Ohio
- The Ohio State University - Columbus
Pennsylvania
- Allegheny-Singer Research Institute - Pittsburgh
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 100 participants |
| Start Date | 2021-11-17 |
| Est. Completion | 2027-05-17 |
What NCT05314608 shows while recruiting
NCT05314608 is an observational study that tracks outcomes without assigning an intervention. The registered 100 participants enrollment target is mid-sized for trials with a published cap.
The record links to 1 condition, with Subchondral Cyst appearing as the primary indexed condition, and to 1 intervention - of which IntraOsseous BioPlasty® (IOBP®) Surgical Technique into the knee is the first listed.
NCT05314608 lists 5 locations in 5 states (Colorado, Florida, Maryland).
Frequently Asked Questions
What is clinical trial NCT05314608 about?
NCT05314608 is a clinical study titled "Knee Related Subchondral Bone Lesions Treated With IOBP". The study will be a prospective, multicenter clinical study evaluating clinical and patient reported outcome measures of subjects receiving IOBP® surgical technique using Angel cPRP and BMA processing system to treat subchondral bone pathology (SBP).
What is the current status of trial NCT05314608?
This trial is currently recruiting. The enrollment target is 100 participants. The study started on 2021-11-17. Estimated completion is 2027-05-17.
What conditions does trial NCT05314608 study?
This clinical trial studies the following conditions: Subchondral Cyst.
What interventions are being tested in trial NCT05314608?
The interventions under investigation include: IntraOsseous BioPlasty® (IOBP®) Surgical Technique into the knee (COMBINATION_PRODUCT).
Who is sponsoring clinical trial NCT05314608?
This trial is sponsored by Arthrex, which has 12 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05314608 being conducted?
This trial has 5 study locations across Colorado, Florida, Maryland, Ohio, Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01048281 · 100 participants
Clinical & Pathological Studies of Upper Gastrointestinal Carcinoma
- NCT01161199 · 100 participants
The Use of Leukapheresis to Support HIV Pathogenesis Studies
- NCT01327690 · 100 participants · Early Phase 1
Mental Health in Veterans and Families After Group Therapies
- NCT01730781 · 100 participants
Imaging Cannabinoid Receptors Using Positron Emission Tomography (PET) Scanning
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI